BBIO
BridgeBio Pharma, Inc.
-0.59 (-0.86%)67.71USD648K成交股數13.2B市值–本益比(近四季)18.6股價營收比+120.4%營收年增(近四季)2026-10-28下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 244M+120% | 195M+67% | 154M+5543% | 121M+5467% | 111M-48% | 117M+6584% | 2.7M-33% | 2.2M+32% | 211M | 1.7M | 4.1M | 1.6M |
| 營業成本 | 15.0M | 9.9M | 8.1M | 6.6M | 3.7M | 2.6M | 598K | 598K | 598K | 598K | 598K | 599K |
| 毛利 | 229M+114% | 185M+62% | 146M+6745% | 114M+7170% | 107M-49% | 114M+9838% | 2.1M-39% | 1.6M+51% | 211M | 1.1M | 3.5M | 1.0M |
| 毛利率 | 93.8% | 94.9% | 94.7% | 94.6% | 96.7% | 97.7% | 78.1% | 72.4% | 99.7% | 65.7% | 85.4% | 63.5% |
| 研發費用 | 149M | 127M | 116M | 113M | 111M | 111M | 120M | 115M | 141M | 130M | 125M | 107M |
| 銷售管理費用 | 186M | 164M | 158M | 138M | 129M | 106M | 68.8M | 59.5M | 65.8M | 47.6M | 35.8M | 36.1M |
| 營業利益 | −107M-20% | −106M+2% | −140M-27% | −145M-17% | −134M-39248% | −104M-41% | −192M+22% | −176M+20% | 343K | −177M | −158M | −146M |
| 營業利益率 | -43.9% | -54.5% | -90.5% | -120.3% | -121.4% | -89.5% | -7,018.7% | -8,096.8% | 0.2% | -10,167.1% | -3,854.6% | -8,903.0% |
| 稅後淨利 | −156M-15% | −167M-2% | −195M+18% | −185M+145% | −184M+408% | −170M-0% | −164M-8% | −75.5M-53% | −36.2M | −170M | −179M | −161M |
| 淨利率 | -64.0% | -85.6% | -126.2% | -153.2% | -166.2% | -145.4% | -6,012.2% | -3,484.5% | -17.1% | -9,760.9% | -4,387.4% | -9,793.0% |
| 稀釋 EPS | -0.78-18% | -0.84-5% | -1.00+16% | -0.95+144% | -0.95+375% | -0.88-9% | -0.86-20% | -0.39-60% | -0.20 | -0.97 | -1.08 | -0.98 |
| 稀釋股數 | 196M | 195M | 192M | 192M | 191M | 190M | 189M | 188M | 179M | 163M | 163M | 161M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 678M | 880M | 570M | 643M | 749M | 541M | 266M | 408M | 475M | 376M | 505M | 302M |
| 應收帳款 | 254M | 205M | 139M | 117M | 76.9M | 115M | – | – | – | 1.8M | – | – |
| 存貨 | 52.8M | 33.0M | 26.8M | 24.5M | 18.3M | 4.0M | – | – | – | – | – | – |
| 總資產 | 1.2B | 1.4B | 936M | 998M | 1.1B | 882M | 665M | 794M | 849M | 546M | 655M | 504M |
| 有息負債 | 2.7B | 2.7B | 2.0B | 2.0B | 0.00 | 0.00 | 436M | 435M | 435M | 446M | 442M | 440M |
| 總負債 | 3.7B | 3.6B | 3.0B | 2.9B | 2.9B | 2.5B | 1.9B | 1.9B | 1.9B | 1.9B | 1.8B | 1.9B |
| 股東權益 | −2.5B | −2.3B | −2.1B | −1.9B | −1.8B | −1.6B | −1.2B | −1.1B | −1.0B | −1.4B | −1.2B | −1.4B |
| 負債比 | 305.9% | 265.5% | 321.9% | 292.6% | 264.6% | 285.9% | 283.2% | 236.2% | 222.1% | 345.7% | 282.2% | 368.0% |
| 淨現金(現金 − 有息負債) | −2.0B | −1.8B | −1.4B | −1.4B | 749M | 541M | −170M | −27.5M | 40.5M | −70.5M | 63.5M | −138M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −197M-1% | – | – | – | −199M | – | – | −220M | – | – | – |
| 資本支出 | – | 69K | – | – | – | 0.00 | – | – | 695K | – | – | – |
| 自由現金流 | – | −197M-1% | – | – | – | −199M | – | – | −220M | – | – | – |
| 折舊攤銷 | – | 1.2M | – | – | – | 1.3M | – | – | 1.6M | – | – | – |
| 買回庫藏股 | – | 82.5M | – | – | – | 48.3M | – | – | 0.00 | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -101.5% | – | – | – | -170.8% | – | – | -104.3% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 502M
| Reportable | 502M | 100.0% | +126.3% |
|---|
產品／服務2025 年度 · 502M
| 產品 | 362M | 72.2% | +12464.8% |
|---|---|---|---|
| License And Service | 128M | 25.6% | -41.4% |
| Royalty | 11.4M | 2.3% | +6637.3% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 502M | +126.3% | −733M | -146.0% | -3.78 | −447M |
| FY2024 | 222M | +2285.3% | −543M | -244.9% | -2.88 | −522M |
| FY2023 | 9.3M | -88.0% | −653M | -7,021.9% | -3.95 | −529M |
| FY2022 | 77.6M | +11.4% | −485M | -624.1% | -3.26 | −424M |
| FY2021 | 69.7M | +745.1% | −586M | -841.2% | -3.90 | −511M |
| FY2020 | 8.2M | -79.7% | −505M | -6,127.9% | -3.80 | −407M |
| FY2019 | 40.6M | – | −289M | -711.5% | -2.48 | −256M |
| FY2018 | – | – | −169M | –% | -2.12 | −139M |